{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T22:29:50Z","timestamp":1725056990313},"reference-count":39,"publisher":"American Association for Cancer Research (AACR)","issue":"20","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Purpose: Subclinical dissemination as well as persistence after therapy may be difficult to assess on clinical and histologic examinations in patients with mucosa-associated lymphoid tissue (MALT) lymphoma. We have analyzed the use of reverse transcription-PCR (RT-PCR) for the detection of t(11;18)(q21;q21) in histologically infiltrated and normal biopsies at diagnosis and during follow-up to determine its clinical and prognostic effect.<\/jats:p>\n               <jats:p>Experimental Design: Twenty-one patients with t(11;18)(q21;q21)+ MALT lymphoma were included in this retrospective study. Presence of t(11;18)(q21;q21) was determined by RT-PCR done on 316 biopsies of various tissues obtained during staging and follow-up.<\/jats:p>\n               <jats:p>Results: Infiltration with lymphoma was histologically detected in 67 of 316 biopsies, whereas molecular infiltration was established in 104 of 316 biopsies. All histologically positive specimens were also positive in RT-PCR. There was a good concordance (P = 0.0001) between histology and RT-PCR at the time of disease presentation with only one further infiltration site identified by RT-PCR. In 8 of 12 patients with persistent lymphoma, RT-PCR revealed tumor infiltration in histologically unsuspected sites. Eight of nine treated patients with histologic and clinical complete remission (CR) remained RT-PCR positive. CR on RT-PCR was achieved later than histologic CR (between 13-59 months) without any further therapy in five of these eight patients; only one patient with persistent t(11;18)(q21;q21) relapsed histologically.<\/jats:p>\n               <jats:p>Conclusions: This study shows the potential of RT-PCR for t(11;18)(q21;q21) done on routine paraffin-embedded specimens to identify disseminated disease in tissues otherwise not diagnostic of MALT lymphoma involvement. T(11;18)(q21;q21) persistence in patients with clinical and histologic CR does not necessarily require therapeutic intervention.<\/jats:p>","DOI":"10.1158\/1078-0432.ccr-06-0232","type":"journal-article","created":{"date-parts":[[2006,10,24]],"date-time":"2006-10-24T17:41:28Z","timestamp":1161711688000},"page":"6023-6028","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Reverse Transcription-PCR for t(11;18)(q21;q21) Staging and Monitoring in Mucosa-Associated Lymphoid Tissue Lymphoma"],"prefix":"10.1158","volume":"12","author":[{"given":"Berthold","family":"Streubel","sequence":"first","affiliation":[{"name":"1Department of Pathology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Huber","sequence":"additional","affiliation":[{"name":"1Department of Pathology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Wo\u0308hrer","sequence":"additional","affiliation":[{"name":"2Division of Oncology, Department of Internal Medicine I, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Chott","sequence":"additional","affiliation":[{"name":"1Department of Pathology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Raderer","sequence":"additional","affiliation":[{"name":"2Division of Oncology, Department of Internal Medicine I, and"},{"name":"3Center of Excellence in Clinical and Experimental Oncology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2006,10,24]]},"reference":[{"key":"2022061104592226500_B1","doi-asserted-by":"crossref","unstructured":"Chott A, Raderer M. New developments in extracutaneous lymphomas. Semin Cutan Med Surg\u20082000;19:149\u201356.","DOI":"10.1053\/sder.2000.8327"},{"key":"2022061104592226500_B2","doi-asserted-by":"crossref","unstructured":"Isaacson PG, Wright DH. Malignant lymphoma of mucosa associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer\u20081983;52:1410\u20136.","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3"},{"key":"2022061104592226500_B3","doi-asserted-by":"crossref","unstructured":"Isaacson PG. Gastric MALT-lymphoma: from concept to cure. Ann Oncol\u20081999;10:637\u201345.","DOI":"10.1023\/A:1008396618983"},{"key":"2022061104592226500_B4","doi-asserted-by":"crossref","unstructured":"Raderer M, Isaacson PG. Extranodal lymphoma of MALT-type: perspective at the beginning of the 21st century. Expert Rev Anticancer Ther\u20082001;1:53\u201364.","DOI":"10.1586\/14737140.1.1.53"},{"key":"2022061104592226500_B5","doi-asserted-by":"crossref","unstructured":"Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood\u20081999;93:3601\u20139.","DOI":"10.1182\/blood.V93.11.3601.411a47_3601_3609"},{"key":"2022061104592226500_B6","doi-asserted-by":"crossref","unstructured":"Akagi T, Motegi M, Tamura A, et al. A novel gene, MALT1 at 18q21, is involved in t(11;18)(q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene\u20081999;18:5785\u201394.","DOI":"10.1038\/sj.onc.1203018"},{"key":"2022061104592226500_B7","unstructured":"Morgan JA, Yin Y, Borowsky AD, et al. Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res\u20081999;59:6205\u201313."},{"key":"2022061104592226500_B8","doi-asserted-by":"crossref","unstructured":"Streubel B, Simonitsch-Klupp I, Mu\u0308llauer L, et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia\u20082004;18:1722\u20136.","DOI":"10.1038\/sj.leu.2403501"},{"key":"2022061104592226500_B9","doi-asserted-by":"crossref","unstructured":"Rosenwald A, Ott G, Stilgenbauer S, et al. Exclusive detection of t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol\u20081999;155:1817\u201321.","DOI":"10.1016\/S0002-9440(10)65499-5"},{"key":"2022061104592226500_B10","doi-asserted-by":"crossref","unstructured":"Remstein ED, James CD, Kurtin PJ. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol\u20082000;156:1183\u20138.","DOI":"10.1016\/S0002-9440(10)64988-7"},{"key":"2022061104592226500_B11","unstructured":"Isaacson PG, Norton AJ. Mucosa-associated lymphoid tissue (MALT) and the MALT-lymphoma concept. In: Isaacson PG, Norton AJ, editors. Extranodal lymphomas. Edinburgh (UK): Churchill Livingstone; 1994. p. 5\u201314."},{"key":"2022061104592226500_B12","doi-asserted-by":"crossref","unstructured":"Du MQ, Xu CF, Diss TC, et al. Intestinal dissemination of gastric mucosa-associated lymphoid tissue lymphoma. Blood\u20081996;88:4445\u201351.","DOI":"10.1182\/blood.V88.12.4445.bloodjournal88124445"},{"key":"2022061104592226500_B13","unstructured":"Dogan A, Du M, Koulis A, Briskin MJ, Isaacson PG. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa associated lymphoid tissue. Am J Pathol\u20081997;151:1361\u20139."},{"key":"2022061104592226500_B14","doi-asserted-by":"crossref","unstructured":"Brandtzaeg P, Farstad I, Haraldsen G. Regional specialization of the mucosal immune system: primed cells do not always home along the same track. Immunol Today\u20081999;20:267\u201377.","DOI":"10.1016\/S0167-5699(99)01468-1"},{"key":"2022061104592226500_B15","doi-asserted-by":"crossref","unstructured":"Raderer M, Wo\u0308hrer S, Streubel B, et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single center experience. J Clin Oncol\u20082006;24:3136\u201341.","DOI":"10.1200\/JCO.2006.06.0723"},{"key":"2022061104592226500_B16","doi-asserted-by":"crossref","unstructured":"Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analysed. Blood\u20082000;95:802\u20136.","DOI":"10.1182\/blood.V95.3.802.003k19_802_806"},{"key":"2022061104592226500_B17","doi-asserted-by":"crossref","unstructured":"Wotherspoon AC, Doglioni C, Isaacson PG. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology\u20081992;20:29\u201334.","DOI":"10.1111\/j.1365-2559.1992.tb00912.x"},{"key":"2022061104592226500_B18","unstructured":"Isaacson PG, Mu\u0308ller-Hermelink HK, Piris MA. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours: tumours of haematopoietic and lymphoid tissues. Lyon (France): IARC Press; 2001. p. 157\u201360."},{"key":"2022061104592226500_B19","doi-asserted-by":"crossref","unstructured":"Inagaki H, Okabe M, Seto M, Nakamura S, Ueda R, Eimoto T. API2-1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma. Multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. Am J Pathol\u20082001;158:699\u2013706.","DOI":"10.1016\/S0002-9440(10)64012-6"},{"key":"2022061104592226500_B20","doi-asserted-by":"crossref","unstructured":"Du MQ, Diss TC, Dogan A, et al. Clone-specific PCR reveals wide dissemination of gastric MALT lymphoma to the gastric mucosa. J Pathol\u20082000;192:488\u201393.","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH727>3.0.CO;2-J"},{"key":"2022061104592226500_B21","doi-asserted-by":"crossref","unstructured":"Bayerdorffer E, Neubauer A, Rudolph B, et al. MALT lymphoma study group. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet\u20081995;345:1591\u20134.","DOI":"10.1016\/S0140-6736(95)90113-2"},{"key":"2022061104592226500_B22","doi-asserted-by":"crossref","unstructured":"Savio A, Franzin G, Wotherspoon AC, et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood\u20081996;87:1255\u201360.","DOI":"10.1182\/blood.V87.4.1255.bloodjournal8741255"},{"key":"2022061104592226500_B23","doi-asserted-by":"crossref","unstructured":"Neubauer A, Thiede C, Morgner A, et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst\u20081997;89:1350\u20135.","DOI":"10.1093\/jnci\/89.18.1350"},{"key":"2022061104592226500_B24","unstructured":"Montalban C, Santon A, Boixeda D, et al. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica\u20082001;86:609\u201317."},{"key":"2022061104592226500_B25","doi-asserted-by":"crossref","unstructured":"Thiede C, Wundisch T, Alpen B, et al. Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol\u20082001;19:1600\u20139.","DOI":"10.1200\/JCO.2001.19.6.1600"},{"key":"2022061104592226500_B26","doi-asserted-by":"crossref","unstructured":"Bertoni F, Conconi A, Capella C, et al. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood\u20082002;99:2541\u20134.","DOI":"10.1182\/blood.V99.7.2541"},{"key":"2022061104592226500_B27","doi-asserted-by":"crossref","unstructured":"de Mascarel A, Ruskone-Fourmestraux A, Lavergne-Slove A, Megraud F, Dubus P, Merlio JP. Clinical, histological, and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue. Virchows Arch\u20082005;446:219\u201324.","DOI":"10.1007\/s00428-005-1217-3"},{"key":"2022061104592226500_B28","doi-asserted-by":"crossref","unstructured":"Fischbach W, Goebeler-Kolve M, Starostik P, Greiner A, Muller-Hermelink HK. Minimal residual low-grade gastric MALT-type lymphoma after eradication of. Helicobacter pylori. Lancet\u20082002;360:547\u20138.","DOI":"10.1016\/S0140-6736(02)09711-8"},{"key":"2022061104592226500_B29","doi-asserted-by":"crossref","unstructured":"Montalban C, Santon A, Garcia-Cosio M, et al. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study. Ann Oncol\u20082005;16:1539\u201344.","DOI":"10.1093\/annonc\/mdi277"},{"key":"2022061104592226500_B30","doi-asserted-by":"crossref","unstructured":"Alpen B, Kuse R, Parwaresch R, Muller-Hermelink HK, Stolte M, Neubauer A. Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy. J Clin Oncol\u20082004;22:3039\u201345.","DOI":"10.1200\/JCO.2004.08.177"},{"key":"2022061104592226500_B31","doi-asserted-by":"crossref","unstructured":"Salar A, Bellosillo B, Serrano S, Besses C. Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab. J Clin Oncol\u20082005;23:7361\u20132.","DOI":"10.1200\/JCO.2005.02.6138"},{"key":"2022061104592226500_B32","doi-asserted-by":"crossref","unstructured":"Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to eradication therapy. Lancet\u20082001;357:39\u201340.","DOI":"10.1016\/S0140-6736(00)03571-6"},{"key":"2022061104592226500_B33","doi-asserted-by":"crossref","unstructured":"Wundisch T, Thiede C, Morgner A, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol\u20082005;23:8018\u201324.","DOI":"10.1200\/JCO.2005.02.3903"},{"key":"2022061104592226500_B34","doi-asserted-by":"crossref","unstructured":"Inagaki H, Nakamura T, Li C, et al. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter Pylori eradication and detection of API2-1 fusion. Am J Surg Pathol\u20082004;28:1560\u20137.","DOI":"10.1097\/00000478-200412000-00003"},{"key":"2022061104592226500_B35","doi-asserted-by":"crossref","unstructured":"Raderer M, Wo\u0308hrer S, Bartsch R, et al. Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. J Clin Oncol\u20082005;23:8442\u20136.","DOI":"10.1200\/JCO.2004.00.8532"},{"key":"2022061104592226500_B36","doi-asserted-by":"crossref","unstructured":"Hammel P, Haioun C, Chaumette M, et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol\u20081995;13:2524\u20139.","DOI":"10.1200\/JCO.1995.13.10.2524"},{"key":"2022061104592226500_B37","doi-asserted-by":"crossref","unstructured":"Jaeger G, Neumeister P, Brezinschek R, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue-type with cladribine: a phase II study. J Clin Oncol\u20082002;20:3872\u20137.","DOI":"10.1200\/JCO.2002.05.117"},{"key":"2022061104592226500_B38","doi-asserted-by":"crossref","unstructured":"Zinzani PL, Stefoni V, Musuraca G, et al. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer\u20082004;100:2190\u20134.","DOI":"10.1002\/cncr.20237"},{"key":"2022061104592226500_B39","doi-asserted-by":"crossref","unstructured":"Raderer M, Streubel B, Woehrer S, et al: High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res\u20082005;11:3349\u201352.","DOI":"10.1158\/1078-0432.CCR-04-2282"}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/12\/20\/6023\/1966207\/6023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/12\/20\/6023\/1966207\/6023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T19:34:58Z","timestamp":1654976098000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/12\/20\/6023\/191516\/Reverse-Transcription-PCR-for-t-11-18-q21-q21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,15]]},"references-count":39,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2006,10,24]]},"published-print":{"date-parts":[[2006,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-06-0232","relation":{},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,15]]}}}